Literature DB >> 2138847

Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening.

J F Lewis1, B J Maron.   

Abstract

In selected patients with systemic hypertension it may be difficult to ascertain whether left ventricular (LV) hypertrophy is a secondary end-organ consequence of long-term elevations in blood pressure or, alternatively, a manifestation of a coexistent primary hypertrophic cardiomyopathy. To address this issue and better characterize LV hypertrophy in systemic hypertension, 2-dimensional echocardiography was used to define the patterns of LV hypertrophy in 102 patients with sustained systemic hypertension and marked degrees of wall thickening. Patients ranged in age from 31 to 88 years (mean 61) and were predominantly female (58%); all were black. By selection, each patient had a maximal LV wall thickness of greater than 15 mm (range 16 to 29). Distribution of hypertrophy was judged to be symmetric (i.e., concentric) in most patients (67 of 102, 66%). However, a substantial proportion (35 patients, 34%) demonstrated nonuniform, asymmetric patterns of hypertrophy in which at least 1 segment of the LV wall was at least 1.5 times the thickness of any other. In these 35 patients, the distribution of hypertrophy was similar to that characteristic of the morphologic spectrum of hypertrophic cardiomyopathy, with thickening of portions of both the ventricular septum and free wall in 16 patients, anterior and posterior ventricular septum alone in 11 patients and segmental involvement of only the anterior ventricular septum in 8. Patients with asymmetric patterns of wall thickening did not differ from the patients with symmetric hypertrophy with regard to age, sex or clinical findings. Asymmetric LV hypertrophy appears to represent an important feature of the morphologic spectrum of severe hypertensive heart disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2138847     DOI: 10.1016/0002-9149(90)91429-a

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy.

Authors:  K Prasad; J Atherton; G C Smith; W J McKenna; M P Frenneaux; P Nihoyannopoulos
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Subaortic membrane mimicking hypertrophic cardiomyopathy.

Authors:  Mark Joseph Anderson; Adelaide Arruda-Olson; Bernard Gersh; Jeffrey Geske
Journal:  BMJ Case Rep       Date:  2015-11-04

3.  Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.

Authors:  Christian Voigt; Julia Münch; Maxim Avanesov; Anna Suling; Katrin Witzel; Gunnar Lund; Monica Patten
Journal:  Clin Cardiol       Date:  2017-07-24       Impact factor: 2.882

4.  Prevalence, clinical correlates, and prognosis of discrete upper septal thickening on echocardiography: the Framingham Heart Study.

Authors:  Tulio Diaz; Michael J Pencina; Emelia J Benjamin; Jayashri Aragam; Deborah L Fuller; Karol M Pencina; Daniel Levy; Ramachandran S Vasan
Journal:  Echocardiography       Date:  2008-10-23       Impact factor: 1.724

Review 5.  The 'athletic heart syndrome'. A critical review.

Authors:  K P George; L A Wolfe; G W Burggraf
Journal:  Sports Med       Date:  1991-05       Impact factor: 11.136

Review 6.  Epidemiology of the inherited cardiomyopathies.

Authors:  William J McKenna; Daniel P Judge
Journal:  Nat Rev Cardiol       Date:  2020-09-07       Impact factor: 32.419

7.  Distribution of myocardial work in arterial hypertension: insights from non-invasive left ventricular pressure-strain relations.

Authors:  Bart Bijnens; Marta Sitges; Filip Loncaric; Maciej Marciniak; Loredana Nunno; Maria Mimbrero; Joao F Fernandes; Dora Fabijanovic; Laura Sanchis; Adelina Doltra; Silvia Montserrat; Maja Cikes; Pablo Lamata
Journal:  Int J Cardiovasc Imaging       Date:  2020-08-12       Impact factor: 2.357

8.  Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy.

Authors:  Ermelinda Pennacchini; Maria Beatrice Musumeci; Stefano Fierro; Pietro Francia; Camillo Autore
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-13       Impact factor: 3.738

9.  Can left ventricular function parameters be determined within half of the time with MRI?

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2007-07-25       Impact factor: 2.357

Review 10.  Should there be sex-specific criteria for the diagnosis and treatment of heart failure?

Authors:  Lawrence E Greiten; Sara J Holditch; Shivaram Poigai Arunachalam; Virginia M Miller
Journal:  J Cardiovasc Transl Res       Date:  2013-11-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.